NXGN - NextGen Healthcare Inc Stock Price, Fair Value and News

104.70USD-2.10 (-1.97%)Market Closed

Market Summary

USD104.70-2.10

Market Closed

-1.97%

NXGN Stock Price

View Fullscreen

NXGN RSI Chart

NXGN Valuation

Market Cap

7.0B

Price/Earnings (Trailing)

-1.2K

Price/Sales (Trailing)

10.31

EV/EBITDA

460.85

Price/Free Cashflow

-765.92

NXGN Price/Sales (Trailing)

NXGN Profitability

EBT Margin

-0.10%

Return on Equity

-1.47%

Return on Assets

-0.72%

Free Cashflow Yield

-0.13%

NXGN Fundamentals

NXGN Revenue

Revenue (TTM)

695.1M

Rev. Growth (Yr)

10.65%

Rev. Growth (Qtr)

-1%

NXGN Earnings

Earnings (TTM)

-6.2M

Earnings Growth (Yr)

-62.89%

Earnings Growth (Qtr)

-17.88%

Breaking Down NXGN Revenue

Last 7 days

-11.3%

Last 30 days

-2.3%

Last 90 days

-23.0%

Trailing 12 Months

501.7%

How does NXGN drawdown profile look like?

NXGN Financial Health

Current Ratio

2.52

Debt/Equity

0.63

Debt/Cashflow

-0.03

NXGN Investor Care

Buy Backs (1Y)

0.75%

Diluted EPS (TTM)

-0.1

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	653.2M	678.1M	695.1M	0
2022	596.4M	603.6M	613.7M	625.9M
2021	556.8M	572.0M	581.3M	589.3M
2020	540.2M	539.3M	545.0M	549.0M
2019	529.2M	527.8M	531.8M	538.6M
2018	531.0M	533.3M	531.0M	530.2M
2017	509.6M	518.3M	523.8M	527.6M
2016	492.5M	492.5M	494.3M	505.2M
2015	490.2M	494.5M	499.3M	493.0M
2014	444.7M	453.0M	462.5M	477.0M
2013	444.7M	444.7M	444.7M	444.7M
2012	460.2M	451.5M	446.4M	440.8M
2011	353.4M	388.7M	423.4M	446.0M
2010	291.8M	308.1M	317.9M	334.8M
2009	245.5M	257.1M	268.7M	280.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of NextGen Healthcare Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 09, 2023	klapstein julie d	back to issuer	-	-	-70,104	-
Nov 09, 2023	waters mitchell	back to issuer	-	-	-57,931	evp, commercial growth
Nov 09, 2023	panner morris	back to issuer	-	-	-100,043	-
Nov 09, 2023	velamoor srinivas s	back to issuer	-	-	-361,586	see remarks
Nov 09, 2023	mcginty geraldine	back to issuer	-	-	-32,877	-
Nov 09, 2023	sides david william	back to issuer	-	-	-605,540	president and ceo
Nov 09, 2023	margolis jeffrey h	back to issuer	-	-	-136,393	-
Nov 09, 2023	puryear pamela	back to issuer	-	-	-31,028	-
Nov 09, 2023	bristol george h	back to issuer	-	-	-82,889	-
Nov 09, 2023	ahmadzai david	back to issuer	-	-	-44,555	chief accounting officer

Which funds bought or sold NXGN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Mar 22, 2024	PNC Financial Services Group, Inc.	sold off	-100	-86,520	-	-%
Mar 11, 2024	VANGUARD GROUP INC	sold off	-100	-165,558,000	-	-%
Mar 06, 2024	SageView Advisory Group, LLC	sold off	-100	-368,053	-	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	sold off	-100	-18,558,300	-	-%
Feb 28, 2024	AMERICAN INTERNATIONAL GROUP, INC.	sold off	-100	-714,795	-	-%
Feb 26, 2024	Virtu Financial LLC	sold off	-100	-459,000	-	-%
Feb 26, 2024	TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	sold off	-100	-423,000	-	-%
Feb 16, 2024	PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	sold off	-100	-1,189,000	-	-%
Feb 16, 2024	PRICE T ROWE ASSOCIATES INC /MD/	sold off	-100	-1,263,000	-	-%
Feb 15, 2024	Legal & General Group Plc	sold off	-100	-3,756,790	-	-%

Are Funds Buying or Selling NXGN?

Are funds buying NXGN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NXGN

No. of Funds

Unveiling NextGen Healthcare Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Oct 10, 2023	vanguard group inc	10.40%	6,976,720	SC 13G/A
Jun 16, 2023	three prong investments, llc	14.99%	9,889,827	SC 13G
Feb 09, 2023	vanguard group inc	9.45%	6,389,869	SC 13G/A
Jan 27, 2023	blackrock inc.	14.3%	9,663,011	SC 13G/A
Jan 23, 2023	blackrock inc.	14.4%	9,760,374	SC 13G/A
Feb 10, 2022	vanguard group inc	9.50%	6,495,700	SC 13G/A
Jan 27, 2022	blackrock inc.	14.5%	9,930,776	SC 13G/A
Jan 25, 2022	blackrock inc.	14.5%	9,930,776	SC 13G/A
Jan 10, 2022	brown capital management llc	2.19%	1,495,268	SC 13G/A
Nov 10, 2021	brown capital management llc	7.50%	5,129,916	SC 13G/A

Peers (Alternatives to NextGen Healthcare Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	441.4B	371.6B	-1.70%	-5.10%	19.72	1.19	14.64%	11.24%
CI	101.2B	195.3B	-1.86%	33.27%	18.83	0.52	8.17%	-20.79%
CVS	86.3B	357.8B	-11.58%	-9.18%	10.33	0.24	10.95%	93.52%
HCA	82.3B	65.0B	-4.91%	14.61%	15.7	1.27	7.86%	-7.11%
CNC	38.5B	154.0B	-6.56%	4.41%	14.25	0.25	6.54%	124.79%
DVA	11.2B	12.1B	-6.85%	52.87%	16.19	0.92	4.57%	23.40%
UHS	11.1B	14.3B	-9.76%	16.96%	15.45	0.78	6.59%	6.24%
MID-CAP
CHE	9.1B	2.3B	-6.80%	8.45%	33.56	4.04	6.06%	9.17%
ACHC	6.5B	2.9B	-10.10%	-6.68%	-299.27	2.21	12.20%	-107.93%
AMN	2.1B	3.8B	-10.37%	-33.80%	10.13	0.56	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.48%	-7.06%	34.15	1.5	21.19%	34.42%
SMALL-CAP
ADUS	1.6B	1.1B	-4.65%	-11.57%	25.08	1.48	11.31%	35.83%
BKD	1.2B	3.0B	5.90%	51.29%	-6.47	0.41	6.74%	20.73%
BEAT	56.9M	-	-6.90%	0.47%	-3.88	-	-	-12.94%
AMS	18.7M	21.3M	15.18%	4.04%	35.15	0.88	8.00%	-62.25%

NextGen Healthcare Inc News

Latest updates

NextGen Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	-1.0%	176	178	179	162	159	153	151	150	149	146	144	142	140	131	136	138	134	132	135	131	130
Gross Profit	2.3%	82.00	80.00	85.00	77.00	77.00	73.00	75.00	76.00	77.00	73.00	74.00	71.00	71.00	65.00	68.00	70.00	69.00	67.00	73.00	69.00	69.00
Operating Expenses	4.0%	74.00	71.00	108	67.00	68.00	72.00	73.00	68.00	84.00	70.00	75.00	70.00	61.00	63.00	74.00	66.00	62.00	65.00	66.00	63.00	54.00
S&GA Expenses	12.4%	54.00	48.00	83.00	46.00	45.00	49.00	50.00	47.00	64.00	48.00	49.00	49.00	42.00	41.00	43.00	43.00	39.00	40.00	45.00	41.00	34.00
R&D Expenses	-13.9%	18.00	21.00	20.00	20.00	21.00	22.00	19.00	19.00	19.00	19.00	21.00	18.00	18.00	18.00	21.00	20.00	20.00	22.00	20.00	21.00	18.00
EBITDA Margin	-40.1%	0.02*	0.04*	0.02*	0.06*	0.06*	0.02*	0.02*	0.02*	0.01*	0.04*	0.04*	0.03*	-	-	-	-	-	-	-	-	-
Interest Expenses	2.2%	3.00	3.00	3.00	2.00	0.00	0.00	1.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	1.00	1.00	1.00
Income Taxes	-31.3%	2.00	2.00	0.00	1.00	6.00	-0.25	2.00	3.00	-1.44	1.00	-0.39	-0.17	-1.30	2.00	-1.96	-1.40	1.00	-0.38	2.00	0.00	2.00
Earnings Before Taxes	-21.6%	7.00	9.00	-24.76	9.00	19.00	1.00	2.00	8.00	-8.21	3.00	-0.97	0.00	9.00	1.00	-6.21	3.00	7.00	1.00	6.00	5.00	15.00
EBT Margin	-105.6%	0.00*	0.02*	0.01*	0.05*	0.05*	0.00*	0.01*	0.00*	-0.01*	0.02*	0.02*	0.01*	-	-	-	-	-	-	-	-	-
Net Income	-17.9%	5.00	6.00	-25.24	8.00	14.00	1.00	0.00	5.00	-6.77	3.00	-0.58	0.00	10.00	-0.82	-4.24	4.00	6.00	1.00	4.00	5.00	13.00
Net Income Margin	-357.5%	-0.01*	0.00*	0.00*	0.04*	0.03*	0.00*	0.00*	0.00*	-0.01*	0.02*	0.02*	0.01*	-	-	-	-	-	-	-	-	-
Free Cashflow	-14.8%	-9.82	-8.55	7.00	2.00	37.00	-5.10	16.00	16.00	19.00	-0.69	20.00	27.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-1.2%	858	868	896	871	627	608	628	605	636	625	644	656	672	770	720	623	573	567	533	531	536
Current Assets	-3.2%	363	375	402	390	218	193	212	186	211	194	208	217	225	317	260	153	170	156	160	158	159
Cash Equivalents	-23.4%	54.00	70.00	99.00	242	78.00	48.00	67.00	54.00	82.00	70.00	79.00	94.00	109	200	140	32.00	50.00	37.00	35.00	37.00	40.00
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00
Net PPE	-11.2%	5.00	6.00	6.00	7.00	7.00	8.00	9.00	11.00	12.00	13.00	15.00	15.00	17.00	19.00	20.00	22.00	22.00	23.00	21.00	23.00	25.00
Goodwill	0.1%	322	322	322	321	267	267	267	267	267	267	267	267	267	267	267	19.00	5.00	219	219	219	219
Liabilities	-5.1%	434	458	496	453	185	179	205	194	200	186	213	230	253	366	320	223	182	186	157	165	180
Current Liabilities	-14.3%	144	168	198	154	169	158	181	170	171	155	181	160	137	138	143	137	132	128	128	120	119
Long Term Debt	0.2%	268	267	267	267	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	0.2%	268	267	267	267	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	3.1%	423	411	400	418	442	429	423	411	435	439	432	426	420	404	400	400	391	381	376	365	355
Retained Earnings	3.8%	139	134	128	153	145	131	130	130	125	131	129	129	129	118	119	123	119	113	112	108	103
Additional Paid-In Capital	1.9%	371	364	359	352	344	337	330	318	312	308	304	298	292	287	283	277	273	268	265	258	254
Accumulated Depreciation	-4.3%	58.00	60.00	61.00	63.00	68.00	68.00	69.00	70.00	68.00	67.00	65.00	63.00	63.00	61.00	59.00	57.00	55.00	53.00	51.00	49.00	48.00
Shares Outstanding	0.1%	67.00	67.00	66.00	66.00	68.00	68.00	67.00	68.00	67.00	67.00	67.00	67.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	975	-	-	-	794	-	-	-	705	-	-	-	850	-	-	-	1,071

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	-16.3%	-9,418	-8,097	7,683	2,181	38,441	-4,645	16,909	16,157	20,166	313	22,540	27,946	30,360	17,672	21,230	23,607	23,767	16,997	17,196	18,363	11,904
Share Based Compensation	19.0%	9,466	7,956	6,942	9,063	8,687	8,766	7,867	7,050	5,223	6,412	5,947	5,933	5,437	5,393	5,866	4,621	4,316	4,891	4,153	4,698	4,135
Cashflow From Investing	56.8%	-7,202	-16,686	-151,732	-56,573	864	-9,453	-8,208	-6,476	-6,858	-6,540	-7,879	-7,613	-6,825	-6,228	-5,231	-78,247	-4,170	-8,424	-6,562	-5,641	-6,356
Cashflow From Financing	25.3%	-2,426	-3,248	566	225,484	-9,322	-4,105	3,696	-36,895	-1,794	-2,298	-29,817	-35,447	-115,045	48,592	91,834	36,695	-5,956	-6,305	-13,555	-14,997	106
Buy Backs	-	-	-	-	40,000	7,373	2,505	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

NXGN Income Statement

2023-09-30

Condensed Consolidated Statements of Net Income and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
Total revenues	$ 176,418	$ 159,443	$ 354,625	$ 312,745
Cost of revenue:
Amortization of capitalized software costs and acquired intangible assets	7,181	6,744	14,172	13,878
Total cost of revenue	94,797	82,580	193,183	162,634
Gross profit	81,621	76,863	161,442	150,111
Operating expenses:
Selling, general and administrative	54,175	44,886	102,368	93,920
Research and development costs, net	18,020	20,857	38,945	42,652
Amortization of acquired intangible assets	1,189	705	2,377	1,410
Impairment of assets	166	805	525	1,329
Restructuring costs	15	321	105	321
Total operating expenses	73,565	67,574	144,320	139,632
Income from operations	8,056	9,289	17,122	10,479
Interest income	1,520	74	3,189	120
Interest expense	(3,310)	(325)	(6,549)	(655)
Other income, net	430	10,292	1,480	10,287
Income before provision for income taxes	6,696	19,330	15,242	20,231
Provision for income taxes	1,641	5,707	4,031	5,460
Net income	5,055	13,623	11,211	14,771
Other comprehensive income:
Foreign currency translation, net of tax	(76)	(5)	(77)	(33)
Unrealized gain (loss) on marketable securities, net of tax	734		(42)
Comprehensive income	$ 5,713	$ 13,618	$ 11,092	$ 14,738
Net income per share:
Basic	$ 0.08	$ 0.2	$ 0.17	$ 0.22
Diluted	$ 0.07	$ 0.2	$ 0.17	$ 0.22
Weighted-average shares outstanding:
Basic	67,074	67,806	66,749	67,698
Diluted	67,690	68,422	67,280	68,353
Recurring
Revenues:
Total revenues	$ 161,316	$ 143,503	$ 324,690	$ 283,262
Cost of revenue:
Cost of revenue excluding amortization of capitalized software costs and acquired intangible assets	75,585	65,039	154,806	127,283
Software, hardware, and other non-recurring
Revenues:
Total revenues	15,102	15,940	29,935	29,483
Cost of revenue:
Cost of revenue excluding amortization of capitalized software costs and acquired intangible assets	$ 12,031	$ 10,797	$ 24,205	$ 21,473

NXGN Balance Sheet

2023-09-30

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 53,867	$ 98,719
Restricted cash and cash equivalents	4,914	7,269
Marketable securities	146,432	139,612
Accounts receivable, net	89,277	88,498
Contract assets	20,489	19,561
Income taxes receivable	8,134	5,248
Prepaid expenses and other current assets	39,684	42,916
Total current assets	362,797	401,823
Equipment and improvements, net	4,939	6,421
Capitalized software costs, net	59,875	54,516
Operating lease assets	2,615	3,335
Deferred income taxes, net	29,210	29,472
Contract assets, net of current	5,616	5,572
Intangibles, net	24,480	28,968
Goodwill	322,001	321,756
Other assets	46,217	44,238
Total assets	857,750	896,101
Current liabilities:
Accounts payable	10,467	12,022
Contract liabilities	45,932	61,601
Accrued compensation and related benefits	28,407	36,241
Income taxes payable	604	622
Operating lease liabilities	3,471	3,826
Other current liabilities	54,997	83,799
Total current liabilities	143,878	198,111
Contract liabilities, net of current	2,809	10,310
Deferred compensation	8,722	8,033
Convertible senior notes, net, noncurrent	267,565	266,843
Operating lease liabilities, net of current	2,464	4,095
Other noncurrent liabilities	9,037	8,274
Total liabilities	434,475	495,666
Commitments and contingencies (Note 17)
Shareholders' equity:
Common stock, $0.01 par value; authorized 100,000 shares; 71,946 shares and 70,875 shares issued at September 30, 2023 and March 31, 2023, respectively; 67,097 shares and 66,026 shares outstanding at September 30, 2023 and March 31, 2023, respectively	719	709
Treasury stock, at cost, 4,849 shares and 4,849 shares at September 30, 2023 and March 31, 2023, respectively	(85,752)	(85,752)
Additional paid-in capital	371,080	359,342
Accumulated other comprehensive loss	(1,581)	(1,462)
Retained earnings	138,809	127,598
Total shareholders' equity	423,275	400,435
Total liabilities and shareholders' equity	$ 857,750	$ 896,101

About NextGen Healthcare Inc

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is based in Atlanta, Georgia.

CEO	Mr. David William Sides
WEBSITE	nextgen.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2783

NextGen Healthcare Inc Frequently Asked Questions

What is the ticker symbol for NextGen Healthcare Inc? What does NXGN stand for in stocks?

NXGN is the stock ticker symbol of NextGen Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NextGen Healthcare Inc (NXGN)?

As of Wed Apr 17 2024, market cap of NextGen Healthcare Inc is 7.03 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NXGN stock?

You can check NXGN's fair value in chart for subscribers.

What is the fair value of NXGN stock?

You can check NXGN's fair value in chart for subscribers. The fair value of NextGen Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of NextGen Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NXGN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is NextGen Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether NXGN is over valued or under valued. Whether NextGen Healthcare Inc is cheap or expensive depends on the assumptions which impact NextGen Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NXGN.

What is NextGen Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, NXGN's PE ratio (Price to Earnings) is -1153.19 and Price to Sales (PS) ratio is 10.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NXGN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on NextGen Healthcare Inc's stock?

In the past 10 years, NextGen Healthcare Inc has provided 0.217 (multiply by 100 for percentage) rate of return.